Close Menu

NEW YORK (GenomeWeb) – Transgenomic today priced its public offering of stock and warrants, expecting to raise $6.2 million in net proceeds. 

The firm is offering 3,573,899 shares of its common stock, as well as corresponding warrants to purchase 714,780 shares of its stock. The stocks and warrants will be sold in combination with one warrant to purchase .20 of a share of stock for each share of stock sold. The combined price for each share and corresponding warrant is $1.95, Transgenomic said. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.